Neuberger Berman Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $435M | Sell |
885,570
-14,246
| -2% | -$7.73M | 0.33% | 55 |
|
|
2025
Q4 | $521M | Buy |
899,816
+32,200
| +4% | +$18.2M | 0.39% | 40 |
|
|
2025
Q3 | $421M | Sell |
867,616
-54,072
| -6% | -$25.2M | 0.31% | 60 |
|
|
2025
Q2 | $374M | Buy |
921,688
+37,529
| +4% | +$15.7M | 0.29% | 69 |
|
|
2025
Q1 | $440M | Sell |
884,159
-280,613
| -24% | -$152M | 0.37% | 57 |
|
|
2024
Q4 | $606M | Sell |
1,164,772
-72,248
| -6% | -$39.7M | 0.48% | 33 |
|
|
2024
Q3 | $765M | Sell |
1,237,020
-63,027
| -5% | -$37.3M | 0.6% | 27 |
|
|
2024
Q2 | $719M | Buy |
1,300,047
+113,691
| +10% | +$65.1M | 0.59% | 25 |
|
|
2024
Q1 | $690M | Buy |
1,186,356
+13,454
| +1% | +$7.55M | 0.57% | 27 |
|
|
2023
Q4 | $623M | Sell |
1,172,902
-33,973
| -3% | -$16.4M | 0.54% | 34 |
|
|
2023
Q3 | $611M | Buy |
1,206,875
+144,601
| +14% | +$77.1M | 0.56% | 29 |
|
|
2023
Q2 | $554M | Buy |
1,062,274
+10,624
| +1% | +$5.73M | 0.5% | 36 |
|
|
2023
Q1 | $606M | Buy |
1,051,650
+52,225
| +5% | +$29.4M | 0.56% | 28 |
|
|
2022
Q4 | $550M | Sell |
999,425
-187,895
| -16% | -$99.6M | 0.54% | 29 |
|
|
2022
Q3 | $602M | Buy |
1,187,320
+342,108
| +40% | +$191M | 0.63% | 16 |
|
|
2022
Q2 | $459M | Buy |
845,212
+71,799
| +9% | +$39.5M | 0.46% | 35 |
|
|
2022
Q1 | $457M | Sell |
773,413
-18,967
| -2% | -$10.9M | 0.39% | 50 |
|
|
2021
Q4 | $523M | Buy |
792,380
+19,581
| +3% | +$12.2M | 0.41% | 44 |
|
|
2021
Q3 | $437M | Buy |
772,799
+4,977
| +0.6% | +$2.73M | 0.38% | 49 |
|
|
2021
Q2 | $385M | Buy |
767,822
+58,036
| +8% | +$27.4M | 0.34% | 59 |
|
|
2021
Q1 | $323M | Buy |
709,786
+80,493
| +13% | +$38.4M | 0.31% | 69 |
|
|
2020
Q4 | $293M | Buy |
629,293
+85,859
| +16% | +$40.3M | 0.3% | 77 |
|
|
2020
Q3 | $240M | Buy |
543,434
+6,770
| +1% | +$2.8M | 0.28% | 85 |
|
|
2020
Q2 | $194M | Buy |
536,664
+48,322
| +10% | +$16.2M | 0.24% | 107 |
|
|
2020
Q1 | $139M | Buy |
488,342
+222,892
| +84% | +$70.3M | 0.21% | 129 |
|
|
2019
Q4 | $86.3M | Sell |
265,450
-93
| -0% | -$28.2K | 0.1% | 282 |
|
|
2019
Q3 | $77.3M | Buy |
265,543
+70,711
| +36% | +$20.2M | 0.09% | 296 |
|
|
2019
Q2 | $57.2M | Buy |
194,832
+3,481
| +2% | +$959K | 0.07% | 372 |
|
|
2019
Q1 | $52.4M | Buy |
191,351
+29,488
| +18% | +$7.34M | 0.06% | 384 |
|
|
2018
Q4 | $36.2M | Sell |
161,863
-48,899
| -23% | -$11.5M | 0.05% | 422 |
|
|
2018
Q3 | $51.4M | Buy |
210,762
+55,336
| +36% | +$12.7M | 0.06% | 403 |
|
|
2018
Q2 | $32.2M | Buy |
155,426
+42,289
| +37% | +$8.98M | 0.04% | 516 |
|
|
2018
Q1 | $23.4M | Sell |
113,137
-4,357
| -4% | -$915K | 0.03% | 597 |
|
|
2017
Q4 | $22.3M | Sell |
117,494
-3,984
| -3% | -$763K | 0.03% | 607 |
|
|
2017
Q3 | $23M | Sell |
121,478
-3,038
| -2% | -$550K | 0.03% | 579 |
|
|
2017
Q2 | $21.7M | Sell |
124,516
-7,164
| -5% | -$1.2M | 0.03% | 590 |
|
|
2017
Q1 | $20.2M | Sell |
131,680
-5,794
| -4% | -$886K | 0.03% | 590 |
|
|
2016
Q4 | $19.4M | Sell |
137,474
-1,389
| -1% | -$205K | 0.03% | 593 |
|
|
2016
Q3 | $22.1M | Sell |
138,863
-30,050
| -18% | -$4.63M | 0.03% | 571 |
|
|
2016
Q2 | $25M | Sell |
168,913
-399,387
| -70% | -$58.9M | 0.03% | 532 |
|
|
2016
Q1 | $80.5M | Buy |
568,300
+137,961
| +32% | +$18.5M | 0.11% | 258 |
|
|
2015
Q4 | $61M | Buy |
430,339
+274,947
| +177% | +$36.7M | 0.08% | 331 |
|
|
2015
Q3 | $19M | Buy |
155,392
+19,605
| +14% | +$2.55M | 0.02% | 643 |
|
|
2015
Q2 | $17.6M | Sell |
135,787
-28,927
| -18% | -$3.77M | 0.02% | 719 |
|
|
2015
Q1 | $22.1M | Sell |
164,714
-24,758
| -13% | -$3.19M | 0.02% | 668 |
|
|
2014
Q4 | $23.7M | Sell |
189,472
-17,004
| -8% | -$2.07M | 0.02% | 618 |
|
|
2014
Q3 | $25.1M | Buy |
206,476
+660
| +0.3% | +$80.2K | 0.03% | 611 |
|
|
2014
Q2 | $24.3M | Sell |
205,816
-19,966
| -9% | -$2.35M | 0.02% | 611 |
|
|
2014
Q1 | $27.1M | Buy |
225,782
+33,471
| +17% | +$3.98M | 0.03% | 566 |
|
|
2013
Q4 | $21.4M | Buy |
192,311
+23,620
| +14% | +$2.35M | 0.02% | 621 |
|
|
2013
Q3 | $15.5M | Sell |
168,691
-48,884
| -22% | -$4.42M | 0.02% | 686 |
|
|
2013
Q2 | $18.4M | Buy |
+217,575
| New | +$18.1M | 0.02% | 628 |
|
Other funds holding TMO
VCM
Neuberger Berman Group's TMO Position: Q1 2026 in Review
Neuberger Berman Group reduced its Thermo Fisher Scientific (TMO) stake by 1.6% in Q1 2026, selling an estimated $7.73M and leaving 885,570 shares worth $435M. The position accounts for 0.33% of the portfolio, ranked #55.
Neuberger Berman Group first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $765M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Neuberger Berman Group held 885,570 shares of Thermo Fisher Scientific worth $435M as of Q1 2026.
- Neuberger Berman Group sold 14,246 Thermo Fisher Scientific shares in Q1 2026, an estimated $7.73M.
- Thermo Fisher Scientific made up 0.33% of Neuberger Berman Group's portfolio in Q1 2026, its #55 holding.
- Neuberger Berman Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Neuberger Berman Group's Thermo Fisher Scientific position peaked at $765M in Q3 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.